{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T18:57:20Z","timestamp":1790708240328,"version":"4.1.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2018,8,9]],"date-time":"2018-08-09T00:00:00Z","timestamp":1533772800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2018,8,9]],"date-time":"2018-08-09T00:00:00Z","timestamp":1533772800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["U10 DA01714"],"award-info":[{"award-number":["U10 DA01714"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["U10 DA 015815"],"award-info":[{"award-number":["U10 DA 015815"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["U10 DA13038"],"award-info":[{"award-number":["U10 DA13038"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["U10 DA13043"],"award-info":[{"award-number":["U10 DA13043"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["U10 DA13045"],"award-info":[{"award-number":["U10 DA13045"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["UG1 DA013035"],"award-info":[{"award-number":["UG1 DA013035"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroimmune Pharmacol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1007\/s11481-018-9801-x","type":"journal-article","created":{"date-parts":[[2018,8,9]],"date-time":"2018-08-09T05:49:46Z","timestamp":1533793786000},"page":"488-497","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":64,"title":["Correlates of Long-Term Opioid Abstinence After Randomization to Methadone Versus Buprenorphine\/Naloxone in a Multi-Site Trial"],"prefix":"10.1007","volume":"13","author":[{"given":"Yuhui","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth A.","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larissa J.","family":"Mooney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Saxon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annamarie","family":"Kelleghan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5809-739X","authenticated-orcid":false,"given":"Yih-Ing","family":"Hser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,8,9]]},"reference":[{"key":"9801_CR1","doi-asserted-by":"publisher","first-page":"S76","DOI":"10.1016\/j.drugalcdep.2006.05.009","volume":"84","author":"M Alegr\u00eda","year":"2006","unstructured":"Alegr\u00eda M, Page JB, Hansen H, Cauce AM, Robles R, Blanco C, Cortes DE, Amaro H, Morales A, Berry P (2006) Improving drug treatment services for Hispanics: research gaps and scientific opportunities. Drug Alcohol Depend 84:S76\u2013S84. \n                    https:\/\/doi.org\/10.1016\/j.drugalcdep.2006.05.009","journal-title":"Drug Alcohol Depend"},{"key":"9801_CR2","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1055\/s-0032-1330033","volume":"46","author":"SM Apelt","year":"2013","unstructured":"Apelt SM, Scherbaum N, G\u00f6lz J, Backmund M, Soyka M (2013) Safety, effectiveness and tolerance of buprenorphine-naloxone in the treatment of opioid dependence: results from a nationwide non-interventional study in routine care. Pharmacopsychiatry 46:94\u2013107. \n                    https:\/\/doi.org\/10.1055\/s-0032-1330033","journal-title":"Pharmacopsychiatry"},{"key":"9801_CR3","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1080\/10550887.2012.694598","volume":"31","author":"G Bart","year":"2012","unstructured":"Bart G (2012) Maintenance medication for opiate addiction: the foundation of recovery. J Addict Dis 31:207\u2013225. \n                    https:\/\/doi.org\/10.1080\/10550887.2012.694598","journal-title":"J Addict Dis"},{"key":"9801_CR4","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.jsat.2014.12.011","volume":"52","author":"BS Bentzley","year":"2015","unstructured":"Bentzley BS, Barth KS, Back SE, Book SW (2015) Discontinuation of buprenorphine maintenance therapy: perspectives and outcomes. J Subst Abus Treat 52:48\u201357. \n                    https:\/\/doi.org\/10.1016\/j.jsat.2014.12.011","journal-title":"J Subst Abus Treat"},{"key":"9801_CR5","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.jsat.2017.01.019","volume":"76","author":"JW Bray","year":"2017","unstructured":"Bray JW, Aden B, Eggman AA, Hellerstein L, Wittenberg E, Nosyk B, Stribling JC, Schackman BR (2017) Quality of life as an outcome of opioid use disorder treatment: a systematic review. J Subst Abus Treat 76:88\u201393. \n                    https:\/\/doi.org\/10.1016\/j.jsat.2017.01.019","journal-title":"J Subst Abus Treat"},{"key":"9801_CR6","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1037\/0893-164X.11.1.26","volume":"11","author":"KB Carey","year":"1997","unstructured":"Carey KB (1997) Reliability and validity of the time-line follow-back interview among psychiatric outpatients: a preliminary report. Psychol Addict Behav 11:26\u201333. \n                    https:\/\/doi.org\/10.1037\/0893-164X.11.1.26","journal-title":"Psychol Addict Behav"},{"key":"9801_CR7","unstructured":"Centers for Disease Control and Prevention (2017) Opioid overdose: drug overdose death data. \n                    https:\/\/wwwcdcgov\/drugoverdose\/data\/statedeathshtml\n                    \n                  . Assessed 26 November 2017"},{"key":"9801_CR8","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.jsat.2005.01.006","volume":"28","author":"S Darke","year":"2005","unstructured":"Darke S, Ross J, Teesson M, Ali R, Cooke R, Ritter A, Lynskey M (2005) Factors associated with 12 months continuous heroin abstinence: findings from the Australian treatment outcome study (ATOS). J Subst Abus Treat 28:255\u2013263. \n                    https:\/\/doi.org\/10.1016\/j.jsat.2005.01.006","journal-title":"J Subst Abus Treat"},{"key":"9801_CR9","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1016\/j.addbeh.2007.01.014","volume":"32","author":"S Darke","year":"2007","unstructured":"Darke S, Ross J, Mills KL, Williamson A, Havard A, Teesson M (2007) Patterns of sustained heroin abstinence amongst long-term, dependent heroin users: 36 months findings from the Australian treatment outcome study (ATOS). Addict Behav 32:1897\u20131906. \n                    https:\/\/doi.org\/10.1016\/j.addbeh.2007.01.014","journal-title":"Addict Behav"},{"key":"9801_CR10","doi-asserted-by":"publisher","first-page":"909","DOI":"10.15288\/jsad.2015.76.909","volume":"76","author":"S Darke","year":"2015","unstructured":"Darke S, Marel C, Slade T, Ross J, Mills KL, Teesson M (2015) Patterns and correlates of sustained heroin abstinence: findings from the 11-year follow-up of the Australian treatment outcome study. J Stud Alcohol Drugs 76:909\u2013915. \n                    https:\/\/doi.org\/10.15288\/jsad.2015.76.909","journal-title":"J Stud Alcohol Drugs"},{"key":"9801_CR11","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1177\/0193841X07307771","volume":"31","author":"ML Dennis","year":"2007","unstructured":"Dennis ML, Foss MA, Scott CK (2007) An eight-year perspective on the relationship between the duration of abstinence and other aspects of recovery. Eval Rev 31:585\u2013612. \n                    https:\/\/doi.org\/10.1177\/0193841X07307771","journal-title":"Eval Rev"},{"key":"9801_CR12","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.drugalcdep.2012.12.010","volume":"131","author":"JA Dreifuss","year":"2013","unstructured":"Dreifuss JA, Griffin ML, Frost K, Fitzmaurice GM, Potter JS, Fiellin DA, Selzer J, Hatch-Maillette M, Sonne SC, Weiss RD (2013) Patient characteristics associated with buprenorphine\/naloxone treatment outcome for prescription opioid dependence: results from a multisite study. Drug Alcohol Depend 131:112\u2013118. \n                    https:\/\/doi.org\/10.1016\/j.drugalcdep.2012.12.010","journal-title":"Drug Alcohol Depend"},{"key":"9801_CR13","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1037\/0022-006X.68.1.134","volume":"68","author":"W Fals-Stewart","year":"2000","unstructured":"Fals-Stewart W, O\u2019Farrell TJ, Freitas TT, McFarlin SK, Rutigliano P (2000) The timeline followback reports of psychoactive substance use by drug-abusing patients: psychometric properties. J Consult Clin Psychol 68:134\u2013144","journal-title":"J Consult Clin Psychol"},{"key":"9801_CR14","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/S0740-5472(03)00125-9","volume":"25","author":"PM Flynn","year":"2003","unstructured":"Flynn PM, Joe GW, Broome KM, Simpson DD, Brown BS (2003) Recovery from opioid addiction in DATOS. J Subst Abus Treat 25:177\u2013186. \n                    https:\/\/doi.org\/10.1016\/S0740-5472(03)00125-9","journal-title":"J Subst Abus Treat"},{"key":"9801_CR15","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1177\/0093854807304345","volume":"34","author":"BR Garner","year":"2007","unstructured":"Garner BR, Knight K, Flynn PM, Morey JT, Simpson DD (2007) Measuring offender attributes and engagement in treatment using the client evaluation of self and treatment. Crim Justice Behav 34:1113\u20131130. \n                    https:\/\/doi.org\/10.1177\/0093854807304345","journal-title":"Crim Justice Behav"},{"issue":"1","key":"9801_CR16","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1300\/J069v26n01_07","volume":"26","author":"Y Hser","year":"2007","unstructured":"Hser Y (2007) Predicting long-term stable recovery from heroin addiction: findings from a 33-year follow-up study. J Addict Dis 26(1):51\u201360","journal-title":"J Addict Dis"},{"key":"9801_CR17","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1001\/archpsyc.58.5.503","volume":"58","author":"YI Hser","year":"2001","unstructured":"Hser YI, Hoffman V, Grella CE, Anglin MD (2001) A 33-year follow-up of narcotics addicts. Arch Gen Psychiatry 58:503\u2013508. \n                    https:\/\/doi.org\/10.1001\/archpsyc.58.5.503","journal-title":"Arch Gen Psychiatry"},{"key":"9801_CR18","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1097\/HRP.0000000000000052","volume":"23","author":"YI Hser","year":"2015","unstructured":"Hser YI, Evans E, Grella C, Ling W, Anglin D (2015) Long-term course of opioid addiction. Harv Rev Psychiatry 23:76\u201389. \n                    https:\/\/doi.org\/10.1097\/HRP.0000000000000052","journal-title":"Harv Rev Psychiatry"},{"key":"9801_CR19","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1111\/add.13238","volume":"111","author":"YI Hser","year":"2016","unstructured":"Hser YI, Evans E, Huang D, Weiss R, Saxon A, Carroll KM, Woody G, Liu D, Wakim P, Matthews AG, Hatch-Maillette M (2016) Long-term outcomes after randomization to buprenorphine\/naloxone versus methadone in a multi-site trial. Addiction 111:695\u2013705. \n                    https:\/\/doi.org\/10.1111\/add.13238","journal-title":"Addiction"},{"key":"9801_CR20","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1097\/ADM.0000000000000274","volume":"11","author":"YI Hser","year":"2017","unstructured":"Hser YI, Huang D, Saxon AJ, Woody G, Moskowitz AL, Matthews AG, Ling W (2017) Distinctive trajectories of opioid use over an extended follow-up of patients in a multisite trial on buprenorphine\u200a+\u200analoxone and methadone. J Addict Med 11:63\u201369. \n                    https:\/\/doi.org\/10.1097\/ADM.0000000000000274","journal-title":"J Addict Med"},{"key":"9801_CR21","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1097\/ADM.0000000000000166","volume":"9","author":"K Kampman","year":"2015","unstructured":"Kampman K, Jarvis M (2015) American Society of Addiction Medicine (ASAM) National Practice Guideline for the use of medications in the treatment of addiction involving opioid use. J Addict Med 9:358\u2013367. \n                    https:\/\/doi.org\/10.1097\/ADM.0000000000000166","journal-title":"J Addict Med"},{"key":"9801_CR22","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.jsat.2007.04.014","volume":"33","author":"AB Laudet","year":"2007","unstructured":"Laudet AB (2007) What does recovery mean to you? Lessons from the recovery experience for research and practice. J Subst Abus Treat 33:243\u2013256","journal-title":"J Subst Abus Treat"},{"key":"9801_CR23","doi-asserted-by":"publisher","first-page":"189","DOI":"10.4088\/JCP.14m09096","volume":"76","author":"KA McDermott","year":"2015","unstructured":"McDermott KA, Griffin ML, Connery HS, Hilario EY, Fiellin DA, Fitzmaurice GM, Weiss RD (2015) Initial response as a predictor of 12-week buprenorphine-naloxone treatment response in a prescription opioid dependent population. J Clin Psychiatry 76:189\u2013194. \n                    https:\/\/doi.org\/10.4088\/JCP.14m09096","journal-title":"J Clin Psychiatry"},{"key":"9801_CR24","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1016\/j.jpain.2012.07.007","volume":"13","author":"DC McDonald","year":"2012","unstructured":"McDonald DC, Carlson K, Izrael D (2012) Geographic variation in opioid prescribing in the U.S. J Pain 13:988\u2013996. \n                    https:\/\/doi.org\/10.1016\/j.jpain.2012.07.007","journal-title":"J Pain"},{"key":"9801_CR25","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1080\/09687630600871987","volume":"13","author":"N McKeganey","year":"2006","unstructured":"McKeganey N, Bloor M, Robertson M, Neale J, MacDougall J (2006) Abstinence and drug abuse treatment: results from the drug outcome research in Scotland study. Drug Educ Prev Policy 13:537\u2013550. \n                    https:\/\/doi.org\/10.1080\/09687630600871987","journal-title":"Drug Educ Prev Policy"},{"key":"9801_CR26","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/0740-5472(92)90062-S","volume":"9","author":"AT McLellan","year":"1992","unstructured":"McLellan AT, Kushner H, Metzger D, Peters R, Smith I, Grissom G, Pettinati H, Argeriou M (1992) The fifth edition of the addiction severity index. J Subst Abus Treat 9:199\u2013213","journal-title":"J Subst Abus Treat"},{"key":"9801_CR27","doi-asserted-by":"publisher","first-page":"9","DOI":"10.4137\/SART.S37030","volume":"10","author":"L Naji","year":"2016","unstructured":"Naji L, Dennis BB, Bawor M, Plater C, Pare G, Worster A, Varenbut M, Daiter J, Marsh DC, Desai D, Thabane L (2016) A prospective study to investigate predictors of relapse among patients with opioid use disorder treated with methadone. Subst Abus 10:9\u201318. \n                    https:\/\/doi.org\/10.4137\/SART.S37030","journal-title":"Subst Abus"},{"key":"9801_CR28","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1093\/aje\/kws284","volume":"177","author":"B Nosyk","year":"2013","unstructured":"Nosyk B, Anglin MD, Brecht ML, Lima VD, Hser YI (2013) Characterizing durations of heroin abstinence in the California civil addict program: results from a 33-year observational cohort study. Am J Epidemiol 177:675\u2013682. \n                    https:\/\/doi.org\/10.1093\/aje\/kws284","journal-title":"Am J Epidemiol"},{"key":"9801_CR29","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1111\/j.1521-0391.2014.12092.x","volume":"23","author":"NM Petry","year":"2014","unstructured":"Petry NM, DePhilippis D, Rash CJ, Drapkin M, McKay JR (2014) Nationwide dissemination of contingency management: the veterans administration initiative. Am J Addict 23:205\u2013210. \n                    https:\/\/doi.org\/10.1111\/j.1521-0391.2014.12092.x","journal-title":"Am J Addict"},{"key":"9801_CR30","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1037\/a0032161","volume":"25","author":"SP Reise","year":"2013","unstructured":"Reise SP, Moore TM, Sabb FW, Brown AK, London ED (2013) The Barratt impulsiveness Scale-11: reassessment of its structure in a community sample. Psychol Assess 25:631\u2013642. \n                    https:\/\/doi.org\/10.1037\/a0032161","journal-title":"Psychol Assess"},{"key":"9801_CR31","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.2147\/NDT.S129480","volume":"13","author":"T Rosic","year":"2017","unstructured":"Rosic T, Naji L, Bawor M, Dennis BB, Plater C, Marsh DC, Thabane L, Samaan Z (2017) The impact of comorbid psychiatric disorders on methadone maintenance treatment in opioid use disorder: a prospective cohort study. Neuropsychiatr Dis Treat 13:1399\u20131408. \n                    https:\/\/doi.org\/10.2147\/NDT.S129480","journal-title":"Neuropsychiatr Dis Treat"},{"key":"9801_CR32","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.drugalcdep.2012.08.002","volume":"128","author":"AJ Saxon","year":"2013","unstructured":"Saxon AJ, Ling W, Hillhouse M, Thomas C, Hasson A, Ang A, Doraimani G, Tasissa G, Lokhnygina Y, Leimberger J, Bruce RD (2013) Buprenorphine\/naloxone and methadone effects on laboratory indices of liver health: a randomized trial. Drug Alcohol Depend 128:71\u201376. \n                    https:\/\/doi.org\/10.1016\/j.drugalcdep.2012.08.002","journal-title":"Drug Alcohol Depend"},{"key":"9801_CR33","doi-asserted-by":"publisher","first-page":"737","DOI":"10.2105\/AJPH.2010","volume":"101","author":"CK Scott","year":"2011","unstructured":"Scott CK, Dennis ML, Laudet A, Funk RR, Simeone RS (2011) Surviving drug addiction: the effect of treatment and abstinence on mortality. Am J Public Health 101:737\u2013744. \n                    https:\/\/doi.org\/10.2105\/AJPH.2010","journal-title":"Am J Public Health"},{"key":"9801_CR34","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/978-1-4612-0357-5_3","volume-title":"Measuring alcohol consumption","author":"LC Sobell","year":"1992","unstructured":"Sobell LC, Sobell MB (1992) Timeline follow-back. In: Measuring alcohol consumption. Humana Press, Totowa, NJ, pp 41\u201372"},{"key":"9801_CR35","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1017\/S146114570700836X","volume":"11","author":"M Soyka","year":"2008","unstructured":"Soyka M, Zingg C, Koller G, Kuefner H (2008) Retention rate and substance use in methadone and buprenorphine maintenance therapy and predictors of outcome: results from a randomized study. Int J Neuropsychopharmacol 11:641\u2013653. \n                    https:\/\/doi.org\/10.1017\/S146114570700836X","journal-title":"Int J Neuropsychopharmacol"},{"key":"9801_CR36","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1159\/000468518","volume":"23","author":"M Soyka","year":"2017","unstructured":"Soyka M, Strehle J, Rehm J, B\u00fchringer G, Wittchen HU (2017) Six-year outcome of opioid maintenance treatment in heroin-dependent patients: results from a naturalistic study in a nationally representative sample. Eur Addict Res 23:97\u2013105. \n                    https:\/\/doi.org\/10.1159\/000468518","journal-title":"Eur Addict Res"},{"key":"9801_CR37","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1002\/ajmg.b.32376","volume":"168","author":"H Su","year":"2015","unstructured":"Su H, Li Z, Du J, Jiang H, Chen Z, Sun H, Zhao M (2015) Predictors of heroin relapse: personality traits, impulsivity, COMT gene Val158met polymorphism in a 5-year prospective study in Shanghai, China. Am J Med Genet B Neuropsychiatr Genet 168:712\u2013719. \n                    https:\/\/doi.org\/10.1002\/ajmg.b.32376","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"9801_CR38","unstructured":"Substance Abuse and Mental Health Services Administration (2011) SAMHSA announces a working definition of \u201crecovery\u201d from mental disorders and substance use disorders. \n                    https:\/\/www.samhsa.gov\/newsroom\/press-announcements\/201112220300\n                    \n                  . Accessed 12 June 2017"},{"key":"9801_CR39","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.jsat.2007.06.001","volume":"33","author":"The Betty Ford Institute Consensus Panel","year":"2007","unstructured":"The Betty Ford Institute Consensus Panel (2007) What is recovery? A working definition from the Betty Ford Institute. J Subst Abus Treat 33:221\u2013228","journal-title":"J Subst Abus Treat"},{"key":"9801_CR40","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.drugalcdep.2015.02.030","volume":"150","author":"RD Weiss","year":"2015","unstructured":"Weiss RD, Potter JS, Griffin ML, Provost SE, Fitzmaurice GM, McDermott KA, Srisarajivakul EN, Dodd DR, Dreifuss JA, McHugh RK, Carroll KM (2015) Long-term outcomes from the national drug abuse treatment clinical trials network prescription opioid addiction treatment study. Drug Alcohol Depend 150:112\u2013119. \n                    https:\/\/doi.org\/10.1016\/j.drugalcdep.2015.02.030","journal-title":"Drug Alcohol Depend"},{"key":"9801_CR41","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.jsat.2006.12.009","volume":"33","author":"A Williamson","year":"2007","unstructured":"Williamson A, Darke S, Ross J, Teesson M (2007) The effect of baseline cocaine use on treatment outcomes for heroin dependence over 24 months: findings from the Australian treatment outcome study. J Subst Abus Treat 33:287\u2013293. \n                    https:\/\/doi.org\/10.1016\/j.jsat.2006.12.009","journal-title":"J Subst Abus Treat"},{"key":"9801_CR42","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.drugalcdep.2008.01.015","volume":"95","author":"HU Wittchen","year":"2008","unstructured":"Wittchen HU, Apelt SM, Soyka M, Gastpar M, Backmund M, G\u00f6lz J, Kraus MR, Tretter F, Sch\u00e4fer M, Siegert J, Scherbaum N (2008) Feasibility and outcome of substitution treatment of heroin-dependent patients in specialized substitution centers and primary care facilities in Germany: a naturalistic study in 2694 patients. Drug Alcohol Depend 95:245\u2013257. \n                    https:\/\/doi.org\/10.1016\/j.drugalcdep.2008.01.015","journal-title":"Drug Alcohol Depend"}],"container-title":["Journal of Neuroimmune Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11481-018-9801-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11481-018-9801-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11481-018-9801-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T16:18:30Z","timestamp":1589732310000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11481-018-9801-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,9]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["9801"],"URL":"https:\/\/doi.org\/10.1007\/s11481-018-9801-x","relation":{},"ISSN":["1557-1890","1557-1904"],"issn-type":[{"value":"1557-1890","type":"print"},{"value":"1557-1904","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,9]]},"assertion":[{"value":"14 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Authors disclosing relevant financial interests, activities, relationships, and affiliations are: Andrew J. Saxon: receives royalties as a section editor for UpToDate. All other authors report no financial or other possible conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}}]}}